Device Trial Radar · NCT04722250
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,103
Actual
Start
Apr 2, 2021
Primary completion
Nov 10, 2023
Study completion Dec 2027
Sponsor
- Lead sponsor
- Medtronic CardiovascularPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 25, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this trial is to generate clinical evidence on valve safety and performance of self-expanding (SE) versus balloon-expandable (BE) transcatheter aortic valve replacement (TAVR) in subjects with a small aortic annulus and symptomatic severe native aortic stenosis. Additionally, a stress echocardiography sub-study will be conducted as part of the SMART Trial at select sites. The purpose of the sub-study is to evaluate performance of SE versus BE TAVR in subjects with a small aortic annulus and symptomatic severe native aortic stenosis after undergoing exercise stress echocardiographic testing.
Conditions
- Symptomatic Aortic Stenosis
- Aortic Valve Stenosis
- Aortic Valve Replacement
Interventions
Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV SystemsDevice
TAVR treatment with Medtronic Evolut PRO, PRO+ System or Evolut FX System (where commercially available)
Edwards SAPIEN 3 or SAPIEN 3 Ultra THV SystemsDevice
TAVR treatment with Edwards SAPIEN 3 or SAPIEN 3 Ultra System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality, Disabling Stroke or Heart Failure RehospitalizationTime frame: 12 months
- Bioprosthetic Valve Dysfunction (BVD)Time frame: 12 months
Locations
92 sites in 13 countries. Site status is shown where the registry gives one.
Scripps Memorial Hospital
La Jolla, California
Cedars Sinai Medical Center
Los Angeles, California
Sutter Health
San Francisco, California
89 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.